Baricitinib vs Empagliflozin

## Baricitinib vs Empagliflozin: Overview

This comparison examines the pharmacological differences between **Baricitinib** and **Empagliflozin**.

## Mechanism of Action

**Baricitinib**: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

## Pharmacokinetics

**Half-life**: Baricitinib — 12 hours; Empagliflozin — 12.4 hours.

## Chemical Properties

**Molecular Formula**: Baricitinib — C16H17N7O2S; Empagliflozin — C23H27ClO7.

**Molecular Weight**: Baricitinib — 371.4170 g/mol; Empagliflozin — 450.9100 g/mol.

**Type**: Baricitinib — Small molecule; Empagliflozin — Small molecule.